Ruoxu Liang

A cavity-reduced prefusion RSV F bivalent vaccine elicits durable and protective immunity

Abstract Respiratory syncytial virus (RSV) remains a major cause of severe respiratory disease, and stabilization of the prefusion (preF) conformation of the F glycoprotein is central for vaccine development. Here, we report a structure-guided engineering strategy that enhances p...